Bliss GVS Pharma Limited

NSE:BLISSGVS.NS

127.88 (INR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006
Operating Activities:
Net Income 754.5411,060.7161,277.5981,041.271,289.6511,819.131,794.9061,791.791,481.947960.192705.5821,094.824794.193529.814457.552402.535352.31958.637
Depreciation & Amortization 263.798186.733173.308172.297125.89189.435213.829205.511142.511122.872112.07361.24436.46154.69554.01135.91429.26629.17
Deferred Income Tax 0-182.667-141.05-70.90300000000000000
Stock Based Compensation 38.15739.04357.07798.37600000000000000
Change In Working Capital 30.416-851.191733.725-578.862-692.216-1,830.727-1,407.9781,134.843-83.269-609.365218.568-745.703-378.301-216.257-395.866-234.859-390.762-81.108
Accounts Receivables -445.187-149.981512.907629.256-785.311-1,821.681-370.653975.162-534.635-324.436296.185-1,288.985000000
Inventory -224.218150.032-290.968-268.0118.055-183.339-93.383-109.289-49.73-11.696-0.072-198.424-10.69190.61680.198-195.661-157.218-6.674
Accounts Payables -251.003-63.16183.443-146.762128.413205.156-398.128-0.8960000000000
Other Working Capital 950.824-788.082328.343-793.345-43.373-30.863-1,314.5951,244.132-33.539-597.669218.64-547.279-367.611-406.873-476.064-39.198-233.544-74.434
Other Non Cash Items 1,912.81890.501-745.852-22.484-270.53321.662-424.364-253.58-411.72415.671-213.095-351.646-88.567-131.677-46.736-20.455-0.604-2.225
Operating Cash Flow 1,513.569343.1351,354.806639.694452.796399.5176.3932,878.5641,129.465489.37823.12858.719363.786236.57568.961183.135-9.7814.474
Investing Activities:
Investments In Property Plant And Equipment -283.293-937.99-740.031-91.242-603.149-437.685-282.172-1,517.627-133.093-396.031-574.091-192.046-232.548-105.086-45.214-133.898-20.747-27.391
Acquisitions Net 6.033139.25110.6794.2068.55657.48-210.0330.16.54400-1,088.336000000
Purchases Of Investments -1,152.102-77.073-22.308-436.889-32.219-396.8210-547.818-1.00100-0.1-9.22700000
Sales Maturities Of Investments 51.0622.495-10.679432.68323.663339.341601.0950.10007.263000000
Other Investing Activites -1,044.925775.808-167.412-378.668113.66-297.501242.509-794.937-380.5466.21653.43432.71822.6437.1576.790.2010.7650.907
Investing Cash Flow -1,378.302-77.509-929.751-469.91-489.489-735.186561.432-2,312.464-514.64-389.815-520.657-1,240.501-219.132-97.929-38.424-133.697-19.982-26.484
Financing Activities:
Debt Repayment -88.958-538.953-263.612-163.418-135.553-186.78-1,014.8-566.443-190.154-102.877-250.694-1,157.491000000
Common Stock Issued 23.49520.41522.844000000000000000
Common Stock Repurchased 0518.538240.768000000000000000
Dividends Paid -53.949-54.372-53.265-55.495-125-82.374-74.494-62.722-61.561-86.273-48.897-82.49-78.2-96.539-18.101-7.542-7.378-4.151
Other Financing Activities 0.355-195.013-184.03610.933222.284437.466-685.259-177.792-134.595-346.36646.6471,181.398333.772-15.52.329-33.42755.915-21.251
Financing Cash Flow -147.929-249.385-237.301-207.98-38.269168.312-759.753-240.514-386.31-432.639-2.251,098.908255.572-112.039-15.772-40.96948.537-25.402
Other Information:
Effect Of Forex Changes On Cash -1.50113.957-99.22816.14677.466-51.729-23.62-150.073-3.4430.0010000.00169.9680084.48
Net Change In Cash 1,510.73730.19888.526-22.053.032-219.103-45.548175.513225.072-333.083300.221-82.874400.22626.60884.7338.46918.77437.068
Cash At End Of Period 2,156.153250.069219.871131.345153.425150.393428.571451.493275.98162.598803.721497.182580.056179.83153.22268.48960.0241.246